Biomedical Occupation or Discipline – Page 31

Maze Therapeutics Secures New Partnership for Pompe Drug Development After Sanofi Deal Collapse

1 year ago talkbio0Tagged amsacrine/azacitidine/etoposide, Deal Collapse, Drug Development, Hereditary Diseases, Partnership, Pompe drug, sanofi

Maze Therapeutics, Pompe drug, partnership, Sanofi deal collapse, drug development, genetic diseases

Revolutionizing Healthcare: Streamlining Cell and Gene Therapy Manufacturing (Part 1)

1 year ago talkbio0Tagged Biotechnology, Cell Therapy, Cost Effectiveness, gene therapy, healthcare innovation, Manufacture, Precision Medicine, production, regulatory, scalability

Cell therapy, gene therapy, manufacturing, biotechnology, healthcare innovation, personalized medicine, production challenges, regulatory compliance, scalability, cost-effectiveness.

FDA Approves Apple Watch’s Afib-Tracking App for Clinical Research

1 year ago talkbio0Tagged afib-tracking app, Apple Watch, Certification, Clinical Research, digital health, heart health, medical technology, United States Food and Drug Administration, Wearable Electronic Devices

Apple Watch, afib-tracking app, FDA certification, clinical studies, heart health, medical technology, wearable devices, digital health.

Triomics Secures $15M for AI-Powered Clinical Trial Automation

1 year ago talkbio0Tagged AI, Artificial Intelligence, Automation, Clinical Trials, Drug Development, Health care facility, innovation, Triomics

Triomics, AI, clinical trials, automation, funding, healthcare, innovation, patient matching, drug development

Revolutionizing Cardiac Mapping: J&J’s Biosense Webster Integrates AI into Carto 3 System

1 year ago talkbio0Tagged AI, Artificial Intelligence, Biosense, Cardiac mapping, Carto 3 System, Electrophysiology (science), healthcare innovation, heart mapping, J&J, medical technology, Webster

J&J, Biosense Webster, AI, Carto 3 system, cardiac mapping, heart mapping, electrophysiology, medical technology, healthcare innovation.

Uzedy, Teva, and MedinCell’s Collaborative Effort Yields Success in Phase 3 Trials for Long-Acting Schizophrenia Treatment

1 year ago talkbio0Tagged Collaboration, Injectables, long-acting, Medincell, mental health, Neuroscience discipline, Phase 3 trials, Psychiatry Specialty, Schizophrenia, Teva, Uzedy

Uzedy, Teva, MedinCell, long-acting, schizophrenia, phase 3 trials, treatment, collaboration, mental health, neuroscience, psychiatry, injectable medication.

Revolutionizing Public Health: CBER’s Peter Marks and the Vision to Reduce FDA Visits

1 year ago talkbio0Tagged Biological Factors, CBER, healthcare innovation, Measures, Medical Devices, Peter Marks, Prophylactic behavior, public health medicine (field), Regulatory Affairs, United States Food and Drug Administration, Vaccines

CBER, Peter Marks, FDA, public health, healthcare innovation, regulatory affairs, biologics, vaccines, medical devices, preventive measures.

Revolutionizing Biology: AlphaFold 3 by Isomorphic and DeepMind Expands Beyond Protein Predictions

1 year ago talkbio0Tagged AlphaFold, Artificial Intelligence, biology (field), DeepMind, disease research, Drug Discovery, Isomorphous, Machine Learning, protein predictions, Rotation, Structural Biology

AlphaFold 3, Isomorphic, DeepMind, protein predictions, biology revolution, artificial intelligence, machine learning, structural biology, drug discovery, disease research.